Korean J Health Promot.  2022 Sep;22(3):165-173. 10.15384/kjhp.2022.22.3.165.

Awareness, Knowledge, and Vaccination Status of Meningococcal Meningitis Vaccination: A Comparative Study on International and Korean University Students

• Shin KS
• Sun HY
• Kwak DS
• Yoo BW

• KMID: 2534136
• DOI: http://doi.org/10.15384/kjhp.2022.22.3.165

Abstract

Background
Meningococcal meningitis is a disease that can cause severe and possibly fatal side effects. To prevent the spread of meningococcal meningitis, which is a highly transmissible disease, 16 states in the USA mandate entering college students to receive meningococcal vaccination. Nevertheless, South Korea does not. This study aims to point out the importance of meningococcal vaccination by comparing the level of general knowledge and recognition of the requirement for vaccination among university students in the USA/Canada and Korea.
Methods
The study was conducted using a self-filled questionnaire survey targeting international and Korean students at one of Korea's universities. The survey focused on topics such as knowledge of infectious diseases that can occur at the dormitory residence, infectious agents and routes of meningococcal meningitis infection and infection route, and students' intention to receive meningococcal vaccination.
Results
International university students had a higher awareness of the importance of infectious disease prevention than Korean students (P<0.05) and also had higher meningococcal-related knowledge (P<0.05). International universities strongly recommend meningococcal vaccination compared to Korean universities (P<0.05), and the actual vaccination rate was higher than that of domestic university students (P<0.05).
Conclusions
This study found that the awareness of meningococcal vaccination among Korean university students was lower than that of international university students, and the vaccination rate was also lower. Because students often do not get vaccinated due to low awareness of the meningococcal disease, health education programs can increase their knowledge about infectious diseases and awareness of vaccines. Thus, increasing the vaccination rate.

Keyword

Meningitis; Meningococcus; Awareness; Vaccination; Communicable diseases

Reference

1. Nguyen N, Ashong D. Neisseria Meningitidis [Internet]. Treasure Island: StatPearls Publishing;2022. [cited Jul 22 2022]. Available from: https://www.ncbi.nlm.nih.gov/pubmed/31751039.

2. Pelton SI. The global evolution of meningococcal epidemiology following the introduction of meningococcal vaccines. J Adolesc Health. 2016; 56(2 Suppl):S3–11.

3. Wang B, Santoreneos R, Afzali H, Giles L, Marshall H. Costs of invasive meningococcal disease: a global systematic review. Pharmacoeconomics. 2018; 36(10):1201–22.

4. Clinical practice guidelines for the management of bacterial meningitis in adults in Korea. Infect Chemother. 2012; 44(3):140–63.

5. Sigurdardóttir B, Björnsson OM, Jónsdóttir KE, Erlendsdóttir H, Gudmundsson S. Acute bacterial meningitis in adults. A 20-year overview. Arch Intern Med. 1997; 157(4):425–30.

6. Korea Disease Control and Prevention Agency. 2020 Management Guidelines for Meningococcal Infectious Diseases Administration [Internet]. Cheongju: Korea Disease Control and Prevention Agency;2020. [cited Feb 11, 2020]. Available from: https://www.kdca.go.kr/board/board.es?mid=a20507020000&bid=0019&act=view&list_no=366144.

7. McIntyre PB, O'Brien KL, Greenwood B, van de Beek D. Effect of vaccines on bacterial meningitis worldwide. Lancet. 2012; 380(9854):1703–11.

8. Guedes S, Bertrand-Gerentes I, Evans K, Coste F, Oster P. Invasive meningococcal disease in older adults in North America and Europe: is this the time for action? A review of the literature. BMC Public Health. 2022; 22(1):380.

9. Korea Disease Control and Prevention Agency. 2018 Management Guidelines for Meningococcal Infectious Diseases Administration [Internet]. Cheongju: Korea Disease Control and Prevention Agency;2018. [cited Sep 12, 2018]. Available from: https://www.kdca.go.kr/board/board.es?mid=a20507020000&bid=0019&act=view&list_no=140665.

10. Frasch CE, Bash MC. Neisseria meningitidis Vaccines. In: Madame curie bioscience database [Internet]. Austin (TX): Landes Bioscience;2000-2013. [cited Jul 8, 2022]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK6030/.

11. Isitt C, Cosgrove CA, Ramsay ME, Ladhani SN. Success of 4CMenB in preventing meningococcal disease: evidence from real-world experience. Arch Dis Child. 2020; 105(8):784–90.

12. Centers for Disease Control and Prevention (CDC). Causes and How It Spreads [Internet]. Atlanta (GA): CDC;2022. [cited Apr 7, 2022]. Available from: https://www.cdc.gov/meningococcal/about/causes-transmission.html.

13. Lee SO, Ryu SH, Park SJ, Ryu J, Woo JH, Kim YS. Meningococcal disease in the Republic of Korea army: incidence and serogroups determined by PCR. J Korean Med Sci. 2003; 18(2):163–6.

14. Korea Disease Control and Prevention Agency (KCDA). 2018 guidelines for adult immunization. 2nd ed. Cheongju: KCDA;2018. p. 26.

15. Pollard AJ. Global epidemiology of meningococcal disease and vaccine efficacy. Pediatr Infect Dis J. 2004; 23(12 Suppl):S274–9.

16. Mbaeyi SA, Joseph SJ, Blain A, Wang X, Hariri S, MacNeil JR. Meningococcal disease among college-aged young adults: 2014-2016. Pediatrics. 2019; 143(1):e20182130.

17. Bruce MG, Rosenstein NE, Capparella JM, Shutt KA, Perkins BA, Collins M. Risk factors for meningococcal disease in college students. JAMA. 2001; 286(6):688–93.

18. Rosenstein N, Levine O, Taylor JP, Evans D, Plikaytis BD, Wenger JD, et al. Efficacy of meningococcal vaccine and barriers to vaccination. JAMA. 1998; 279(6):435–9.

19. LaForce FM, Konde K, Viviani S, Préziosi MP. The meningitis vaccine project. Vaccine. 2007; 25 Suppl 1:A97–100.

20. Bousema JC, Ruitenberg J. Need for optimisation of immunisation strategies targeting invasive meningococcal disease in the Netherlands. Int J Health Policy Manag. 2015; 4(11):757–61.

21. Lee SY, Han MA, Park J, Ryu SY. Factors associated with human papillomavirus vaccination and intention among male and female college students. Korean J Health Promot. 2015; 15(3):141–9.

22. Viner RM, Booy R, Johnson H, Edmunds WJ, Hudson L, Bedford H, et al. Outcomes of invasive meningococcal serogroup B disease in children and adolescents (MOSAIC): a case-control study. Lancet Neurol. 2012; 11(9):774–83.

23. Korea Disease Control and Prevention Agency, Infectious Disease Policy Division. Statutory Infectious Disease Occurrence Status [Internet]. Daejeon: Korea Disease Control and Prevention Agency;2021. [cited Apr 7, 2022]. Available from: https://www.index.go.kr/potal/main/EachDtlPageDetail.do?idx_cd=1442.

24. Heo JY. Meningococcal disease in Korea: an epidemiologic study of the underestimated infectious disease. Infect Chemother. 2016; 48(1):51–3.

25. Azzari C, Nieddu F, Moriondo M, Indolfi G, Canessa C, Ricci S, et al. Underestimation of invasive meningococcal disease in Italy. Emerg Infect Dis. 2016; 22(3):469–75.

26. Goodman AL, Masuet-Aumatell C, Halbert J, Zuckerman JN. Awareness of meningococcal disease among travelers from the United Kingdom to the meningitis belt in Africa. Am J Trop Med Hyg. 2014; 91(2):281–6.